DaVita DVA Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Other - Ancillary Services | $494.32M-12.4% | $564.02M+24.7% | $452.12M-6.4% | $482.85M+17.2% | $412.09M-3.1% | |
| Other Operating Segments with Intersegment | $497.61M-12.2% | $566.89M+24.6% | $454.89M-6.3% | $485.69M+17.1% | $414.82M-3.6% | |
| U.S.Dialysis And Related Lab Services | $2.92B— | —— | $2.97B+2.5% | $2.9B+3.0% | $2.81B— | |
| Other revenues by Business | ||||||
| Other - Ancillary Services | $108.51M-40.6% | $182.63M+113% | $85.88M-38.7% | $140.15M+41.6% | $98.95M-37.8% | |
| Other Operating Segments with Intersegment | $136.48M-36.3% | $214.19M+84.9% | $115.86M-30.5% | $166.69M+45.5% | $114.53M-32.4% | |
| Dialysis patient service revenues by Business | ||||||
| Other - Ancillary Services | $248.18M+2.8% | $241.46M+1.6% | $237.63M+5.6% | $224.94M+7.2% | $209.75M+5.3% | |
| Other Operating Segments with Intersegment | $357.84M+2.3% | $349.83M+4.0% | $336.26M+6.4% | $316.16M+6.2% | $297.57M+16.2% | |
| Segment, Expenditure, Addition to Long-Lived Assets by Business | ||||||
| Other - Ancillary Services | $13.58M-42.3% | $23.53M-29.4% | $33.34M+87.5% | $17.78M-40.1% | $29.67M-7.0% | |
| U.S.Dialysis And Related Lab Services | $88.44M— | —— | $132.74M+28.5% | $103.31M-9.1% | $113.59M— | |
| Foreign currency and other adjustments by Business | ||||||
| Other - Ancillary Services | $6.58M— | $0-100% | $10.02M-79.9% | $49.94M+25.0% | $39.95M+165% | |
| U.S.Dialysis | $0— | $0— | $0— | —— | —— | |
| D&A by Business | ||||||
| Other - Ancillary Services | $22.66M-2.5% | $23.23M+9.3% | $21.25M+18.6% | $17.92M-8.3% | $19.55M+16.9% | |
| U.S.Dialysis And Related Lab Services | $155.17M— | —— | $156.24M-0.3% | $156.78M-0.1% | $156.9M— | |
| Acquisitions by Business | ||||||
| Other - Ancillary Services | $9.54M— | —— | $68.09M— | —— | -$4.84M-102% | |
| U.S.Dialysis | $21.1M+321% | $5.01M— | —— | —— | —— | |
| Goodwill by Business | ||||||
| Other - Ancillary Services | $1.03B+1.6% | $1.02B-0.4% | $1.02B+8.3% | $943.17M+5.6% | $893.1M+4.1% | |
| U.S.Dialysis | $6.55B+0.3% | $6.53B+0.1% | $6.52B0.0% | $6.52B— | —— | |
| Goodwill, Impaired, Accumulated Impairment Loss by Business | ||||||
| Other - Ancillary Services | $154.26M-1.6% | $156.74M+0.1% | $156.59M0.0% | $156.58M+6.8% | $146.61M+3.4% | |
| U.S.Dialysis | $0— | —— | $0— | $0— | —— | |
| Goodwill, before accumulated impairment charges by Business | ||||||
| Other - Ancillary Services | $1.19B+1.2% | $1.17B-0.3% | $1.18B+7.1% | $1.1B+5.8% | $1.04B+4.0% | |
| U.S.Dialysis | $6.55B— | —— | $6.52B0.0% | $6.52B— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does DaVita break its business down?
- DaVita (DVA) reports revenue by business across 3 parts — Other - Ancillary Services, Other Operating Segments with Intersegment and U.S.Dialysis And Related Lab Services. Each is extracted from the segment footnotes and tracked over time.
- Where does DaVita's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in DaVita's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
